| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |